查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553704

骨生长刺激产品市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2024-2030 年

Bone Growth Stimulators Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格
简介目录

骨生长刺激产品市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，骨生长刺激产品的全球市场规模预计将达到 15.3 亿美元。

预计2024年至2030年该市场将以5.1%的复合年增长率成长。对非侵入性和微创治疗的需求不断增长是预测期内推动市场成长的关键因素。微创手术的好处包括切口更小、感染疾病风险更低、恢復更快、住院时间更短、疤痕更少以及手术期间失血更少。因此，骨形成蛋白（BMP）和富血小板血浆（PRP）在微创脊椎和整形外科手术中的采用率预计将很高，从而推动市场成长。

预计创伤和事故案例的增加也将成为支持骨生长刺激产品市场成长的主要因素。据世界卫生组织称，每年约有 2,000 万至 5,000 万人在道路事故中受伤。道路交通事故和创伤可能导致骨折延迟或不癒合以及严重的脊椎损伤，预计这将推动对骨生长刺激产品的需求。

骨生长刺激产品市场报告亮点

  • 由于对患者非侵入性治疗和产品进步的高需求，骨骼生长刺激器细分市场将成为 2023 年市场上收益最高的细分市场。
  • 由于 PRP 领域在骨骼和软组织癒合方面的日益普及、良好的安全性以及在再生治疗开发中具有良好成果的潜力，因此在估计和预测期内，PRP 领域将以最高的复合年增长率增长。
  • 就应用领域而言，由于脊椎损伤、骨折和脊椎狭窄的增加，脊椎融合手术领域预计将在2023年占据最大份额，并在预测期内保持其主导地位。
  • 医院部门在整个市场中占据最大份额，由于遭受外伤、道路事故、脊椎损伤和骨折的患者入院数量不断增加，预计在研究期间将保持其主导地位。
  • 北美在2023年主导整个市场的主要原因是该地区拥有几家大型医疗设备公司和高度发展的医疗基础设施。
  • 预计亚太地区骨生长刺激产品市场将在预测期内呈现最高成长率。包括中国、印度和印尼在内的亚洲国家道路交通事故数量的增加和医疗基础设施的发展是促进该地区成长的主要因素。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章全球骨生长刺激产品市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 全球骨骼生长刺激产品市场分析工具
    • 波特的分析
    • PESTEL分析

第四章全球骨生长刺激产品市场：依产品估计与趋势分析

  • 细分仪表板
  • 骨骼生长刺激产品市场：2023 年和 2030 年产品变化分析
  • 骨骼生长刺激剂
  • 骨形成蛋白（BMP）
  • 富血小板血浆 (PRP)

第五章全球骨生长刺激产品市场：按应用估计和趋势分析

  • 细分仪表板
  • 骨骼生长刺激产品市场：2023 年和 2030 年应用变化分析
  • 脊椎融合手术
  • 骨折延迟癒合和不癒合骨折
  • 整形外科创伤手术
  • 其他的

第六章骨生长刺激产品市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 骨骼生长刺激产品市场：2023 年和 2030 年最终用途的变化分析
  • 医院
  • 整形外科诊所
  • 居家照护环境
  • 门诊手术中心

第七章全球骨生长刺激产品市场：区域估计与趋势分析

  • 2023 年及 2030 年骨生长刺激器市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
  • Orthofix Holdings, Inc.
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • Medtronic
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • Zimmer Biomet
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • DePuy Synthes
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • Arthrex, Inc.
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • Bioventus
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • DJO Global, Inc.
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • Ossatec benelux
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • Altis biologics
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • BTT health GMBH
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
  • IGEA
    • 参与企业概况
    • 财务表现
    • 产品基准
  • Isto Biologics
    • 参与企业概况
    • 财务表现
    • 产品基准
    • 最新趋势/策略倡议
简介目录
Product Code: GVR-1-68038-585-4

Bone Growth Stimulators Market Growth & Trends:

The global bone growth stimulators market size is anticipated to reach USD 1.53 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.1% from 2024 to 2030. Escalating demand for noninvasive and minimally invasive treatments is a major factor estimated to boost market growth during the forecast period. Some advantages offered by minimally invasive surgeries are smaller incisions, low risk of infections, speedy recovery, shorter stay at the hospital, reduced scarring, and minimal blood loss during surgery. Thus, there is high adoption of Bone Morphogenetic Proteins (BMP) and Platelet-rich Plasma (PRP) for minimally invasive spinal and orthopedic surgeries, which is expected to boost the market growth.

The rising number of trauma and accident cases is another major factor projected to support the growth of the bone growth stimulator market. According to WHO, around 20 to 50 million people are injured every year due to road accidents. Road accidents and trauma are likely to result in severe spinal injuries as well as delayed union or nonunion of bone fractures, which is projected to drive demand for bone growth stimulators.

Bone Growth Stimulators Market Report Highlights:

  • Bone growth stimulation devices segment was the largest revenue grossing segment of the market in 2023 owing to high demand for noninvasive treatments by patients as well as product advancements.
  • PRP segment is estimated to grow at the highest CAGR during the forecast period owing to its growing popularity for bone and soft tissue healing, as well as its favorable safety profile and potential promising outcome for the development of regenerative treatments.
  • In the application segment, the spinal fusion surgeries segment accounted for the largest share in 2023 and is projected to maintain its dominance during the forecast period owing to the escalating number of spinal injuries, fractures, and spinal stenosis.
  • The hospitals segment accounted for the largest share in the overall market and is expected to maintain its dominance during the study period due to escalating number of admissions of patients suffering from traumatic injuries, road accidents, spinal injuries, and bone fractures.
  • North America dominated the overall market in 2023 mainly due to the existence of several leading medical device companies in this region and highly developed healthcare infrastructure.
  • The Asia Pacific bone growth stimulator market is projected to grow at the highest rate during the forecast period. The rising number of road accidents and developing healthcare infrastructure in Asian countries, including China, India, and Indonesia, are major factors contributing to growth in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Bone Growth Stimulators Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Global Bone Growth Stimulators Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Global Bone Growth Stimulators Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bone Growth Stimulators Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Bone growth stimulation devices
    • 4.3.1. Bone Growth Stimulation Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Bone Morphogenetic Proteins (BMP)
    • 4.4.1. Bone Morphogenetic Proteins (BMP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Platelet-Rich Plasma (PRP)
    • 4.5.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Global Bone Growth Stimulators Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bone Growth Stimulators Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Spinal fusion surgeries
    • 5.3.1. Spinal fusion surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Delayed union & nonunion bone fractures
    • 5.4.1. Delayed union & nonunion bone fractures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Orthopedic trauma surgeries
    • 5.5.1. Orthopedic trauma surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Other Accessories
    • 5.6.1. Other Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Globe Bone Growth Stimulators Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Bone Growth Stimulators Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Specialized Orthopedic Clinics
    • 6.4.1. Specialized Orthopedic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Home Care Settings
    • 6.5.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Ambulatory Surgical Centers
    • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Globe Bone Growth Stimulators Market: Regional Estimates & Trend Analysis

  • 7.1. Bone Growth Stimulators Market Share, By Region, 2023 & 2030 (USD Billion)
  • 7.2. North America
    • 7.2.1. North America Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.3. Europe
    • 7.3.1. Europe Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4. Italy
      • 7.3.4.1. Italy Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.6. Denmark
      • 7.3.6.1. Denmark Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.7. Sweden
      • 7.3.7.1. Sweden Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2. China
      • 7.4.2.1. China Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4. India
      • 7.4.4.1. India Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
  • 8.5. Orthofix Holdings, Inc.
    • 8.5.1. Participant's Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Developments/ Strategic Initiatives
  • 8.6. Medtronic
    • 8.6.1. Participant's Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Developments/ Strategic Initiatives
  • 8.7. Zimmer Biomet
    • 8.7.1. Participant's Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Developments/ Strategic Initiatives
  • 8.8. DePuy Synthes
    • 8.8.1. Participant's Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Developments/ Strategic Initiatives
  • 8.9. Arthrex, Inc.
    • 8.9.1. Participant's Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Developments/ Strategic Initiatives
  • 8.10. Bioventus
    • 8.10.1. Participant's Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Developments/ Strategic Initiatives
  • 8.11. DJO Global, Inc.
    • 8.11.1. Participant's Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Recent Developments/ Strategic Initiatives
  • 8.12. Ossatec benelux
    • 8.12.1. Participant's Overview
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Recent Developments/ Strategic Initiatives
  • 8.13. Altis biologics
    • 8.13.1. Participant's Overview
    • 8.13.2. Financial Performance
    • 8.13.3. Product Benchmarking
    • 8.13.4. Recent Developments/ Strategic Initiatives
  • 8.14. BTT health GMBH
    • 8.14.1. Participant's Overview
    • 8.14.2. Financial Performance
    • 8.14.3. Product Benchmarking
    • 8.14.4. Recent Developments/ Strategic Initiatives
  • 8.15. IGEA
    • 8.15.1. Participant's Overview
    • 8.15.2. Financial Performance
    • 8.15.3. Product Benchmarking
  • 8.16. Isto Biologics
    • 8.16.1. Participant's Overview
    • 8.16.2. Financial Performance
    • 8.16.3. Product Benchmarking
    • 8.16.4. Recent Developments/ Strategic Initiatives